Subcutaneous injection of insulin (4 IU/kg) produced improving effects on body weight loss, hyperglycemia, apoptosis and cardiac hypertrophy induced by intravenous injection of 65 mg/kg of STZ (Kuo et al., 2009 ▶). The gene discussed is INS; the disease is Hyperglycemia.